Stealth BioTherapeutics Corp - ADR

NASDAQ:MITO   3:01:28 PM EDT
0.84
+0.05 (+6.08%)
Earnings Announcements

Stealth BioTherapeutics Reports Third Quarter 2021 Financial Results

Published: 11/11/2021 12:36 GMT
Stealth BioTherapeutics Corp - ADR (MITO) - Stealth Biotherapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights.
Q3 Loss per Share $0.01.
Expects Cash, Cash Equivalents and Investments As of Sept 30 is Sufficient to Fund Planned Operations Into Q3 of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.02

More details on our Analysts Page.